Purchase Order 75A50118P00012
Award Date 7/6/18
Potential Completion Date 10/5/18
Potential Value $42K
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Holly Springs, NC, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The purpose of this Firm Fixed Price Delivery Order is to procure an Influenza A(H2Nx) virus vaccine candidate(s) and conduct the associated clinical trial. The total ceiling value of this contract is $21,404,609.80, with a completion date of January 31, 2027. The prime contractor is Seqirus Inc.,...
- The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $12,900.00 firm fixed-price purchase order to Seqirus, Inc., a division of the global biotechnology company CSL Seqirus, to prepare and transfer MF59 vaccine from a shipping point in Louisville, Kentucky. This order did not have a set-aside designation. Seqirus has a significant $13.4 billion Indefinite Delivery Contract with HHS ASPR to provide medical...
- The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $800,855.47 Firm Fixed Price Delivery Order contract to Seqirus Inc., a foreign-owned for-profit manufacturer of goods. The contract supports Seqirus' ongoing work to provide goods and services related to pandemic preparedness and response, including supply of bulk antigens, adjuvants, influenza seed strains, and storage and testing for the National Pre-Pandemic...
- This contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a foreign-owned, for-profit biotechnology manufacturer, to procure supplies of vaccine bulk lots on behalf of the Department of Defense (DoD). The $171,180 firm fixed-price delivery order has a completion date of February 21, 2022 and does not have a set-aside designation. Seqirus has a broader $13.4 billion Indefinite Delivery...
- This is a federal contract award from the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus, a leading global biotechnology company. The contract, valued at $34,163.00, is for the continuation of a physical chemical compatibility study of the H7N9 influenza vaccine with the MF59 adjuvant for an additional 18 months. The contract is a firm fixed-price purchase order with no set-aside...
- This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, with a ceiling value of $5,574,920.00, was awarded to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The contract is a Delivery Order under the Pandemic Influenza Preparedness and Response 2012-2016 master Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Seqirus USA Inc....
- This federal contract award is for $487,277.80 and was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of global biotechnology company CSL Seqirus. The contract is a delivery order under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC), a $13.4 billion vehicle that serves as the primary mechanism for Seqirus' federal contracting activities...
- This federal contract award was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The $4,705.52 firm-fixed-price delivery order is part of a larger $13.4 billion Indefinite Delivery Contract (IDC) awarded to Seqirus in February 2022 to provide a range of medical countermeasures and related services to support pandemic preparedness...
- This federal contract award to Seqirus Inc. was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC). The $402,112 firm fixed-price delivery order is for the acquisition of medical countermeasures (MCMs) for pandemic influenza preparedness and response, including the production, storage, and stability testing of...
- This federal contract award to Seqirus Inc., a division of CSL Seqirus, is for the H5N8 Short Term Physical Chemical Compatibility Study. The $42,351.55 firm-fixed-price purchase order was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) and did not have a set-aside designation. The contract is for services related to pandemic preparedness and response, including testing and storage of influenza vaccines and seed...